Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
 Vol. 27 No. 7, July 2006
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meck, M. M.
Right arrow Articles by Sills, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meck, M. M.
Right arrow Articles by Sills, R. H.

(Pediatrics in Review. 2006;27:257-263.)
© 2006 American Academy of Pediatrics

Late Effects in Survivors of Childhood Cancer


Mandy M. Meck, MD*
Margaret Leary, MD*
Richard H. Sills, MD*
 * Albany Medical College, Department of Pediatrics, Division of Pediatric Hematology/Oncology, Albany, NY

The first 300 words of the full text of this article appear below.


   Objectives
 
After completing this article, readers should be able to:

  1. Describe common late effects in children who are treated for cancer.
  2. Know the common clinical presentations for the more serious late effects.
  3. Explain how to monitor survivors of childhood cancer for late effects.
  4. Recognize when to refer patients to a pediatric oncologist or other specialist.


   Case Presentation
 
A 19-year-old male was treated for cerebellar medulloblastoma at 3 years of age. Therapy included total resection followed by craniospinal radiation in a dose of 3,600 cGy, with a boost to 5,040 cGy to the tumor bed, as well as chemotherapy with vincristine, cyclophosphamide, and cisplatin. School was a struggle, and he was held back in the 8th grade. One physician suggested methylphenidate therapy, but the boy’s mother refused. He has just graduated from high school but is having difficulty obtaining employment. Now he presents with his fiancée because they want to know if he can father children. He shows no evidence of recurrent disease or complications of his tumor.

Physical examination documents a weight of 60 kg (16th percentile) and height of 158 cm (<3rd percentile). Abnormalities include a 3x4 cm area of alopecia over his occipital region and a posterior midline craniotomy scar. His only neurologic deficit is a mild impairment in upward gaze bilaterally. He has no lymphadenopathy or thyroid abnormalities. He is at Sexual Maturity Rating (SMR) 5.

Results of complete blood count, chemistry profile, and thyroid function tests are normal; the insulin-like growth factor value is low. Semen analysis is normal. Audiogram demonstrates mild-to-moderate bilateral sensorineural hearing loss.

The combined radiation and chemotherapy administered to the boy at a relatively young age would be expected to cause neurocognitive dysfunction. School problems are common for children treated with craniospinal irradiation (even older children), who should be evaluated and problems addressed . . . [Full Text of this Article]






HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics Pediatrics in Review
Copyright © 2006 by the American Academy of Pediatrics.